EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Evaluation of Potential Hit Molecules Against Multiple Serotypes of Dengue Virus Envelope Glycoprotein

Aadhil Haq iD, Samavath Mallawarachchi iD, Aiden Anderson, Leily Khaleghi, Lasan Manujitha iD, Sandun Fernando iD

Molecules · 2025

DOI: 10.3390/molecules30061268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Aadhil Haq und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological and Agricultural Engineering, Texas A&M University, College Station, TX 77840, USA. Hauptthemen laut MEDLINE: Dengue Virus, Viral Envelope Proteins, Antiviral Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue Fever, a widespread mosquito-borne disease caused by the dengue virus (DENV), poses a major health threat in tropical and subtropical regions worldwide, resulting in millions of infections yearly. Severe cases of dengue fever have a mortality rate of around fifteen percent. Currently, there are no antiviral treatments for this disease and the only FDA-approved vaccine has been known to have adverse effects, especially in children. Thus, there is an urgent need for new therapeutics for Dengue fever. The largest issue with developing an antiviral treatment is that DENV has four serotypes that each differ slightly enough to pose problems with one compound inhibiting all four. This study addresses that challenge to some extent by focusing on in silico screening of potential hits targeting the envelope glycoprotein, which is relatively conserved across these four serotypes. Using pharmacophore screening and in silico evaluation of ligands, we identified compounds which could potentially have high affinity to the envelope glycoprotein for two of the four DENV serotypes. These in silico results were validated experimentally using bio-layer interferometry. These findings lay a foundation for in vitro analysis and hit-to-lead studies, advancing the development of antivirals that can inhibit multiple serotypes of the dengue virus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusViral Envelope ProteinsAntiviral AgentsSerogroupComputer SimulationHumansDengueLigands

Stichwörter der Autor:innen

antiviralcomputational drug discoverydengue virusenvelope protein inhibitorserotypes

Substanzen

Viral Envelope ProteinsAntiviral AgentsLigands

Autor:innen und Institutionen

  • Department of Biological and Agricultural Engineering, Texas A&M University, College Station, TX 77840, USA.

ORCID-Profile: Aadhil Haq, Samavath Mallawarachchi, Lasan Manujitha, Sandun Fernando

Zitieren

APA

Haq, A., Mallawarachchi, S., Anderson, A., Khaleghi, L., Manujitha, L., & Fernando, S. (2025). In Silico Evaluation of Potential Hit Molecules Against Multiple Serotypes of Dengue Virus Envelope Glycoprotein. Molecules. https://doi.org/10.3390/molecules30061268

Vancouver

Haq A, Mallawarachchi S, Anderson A, Khaleghi L, Manujitha L, Fernando S. In Silico Evaluation of Potential Hit Molecules Against Multiple Serotypes of Dengue Virus Envelope Glycoprotein. Molecules. 2025. doi:10.3390/molecules30061268

BibTeX
@article{Haq2025,
  author = {Haq, Aadhil and Mallawarachchi, Samavath and Anderson, Aiden and Khaleghi, Leily and Manujitha, Lasan and Fernando, Sandun},
  title = {In Silico Evaluation of Potential Hit Molecules Against Multiple Serotypes of Dengue Virus Envelope Glycoprotein},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30061268}
}
Kostenlos starten →